Clinical Trials
23 trialsPharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
University of Michigan Rogel Cancer Center
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
University of Wisconsin, Madison
OTT15-04
Ottawa Hospital Research Institute
MK-3475-B10
Merck Sharp & Dohme LLC
PADMA
GBG Forschungs GmbH
VIGOR
Galvanize Therapeutics, Inc.
TINES
First Affiliated Hospital Xi'an Jiaotong University
AIRE
Institut fuer Frauengesundheit
MITO16/MANGO-2
National Cancer Institute, Naples
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics
Peking University Third Hospital
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
BATMAN
Hoffmann-La Roche
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
Hoffmann-La Roche
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Hoffmann-La Roche
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Novartis
Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Taipei Veterans General Hospital, Taiwan
LPS-PK-H
Shandong Luye Pharmaceutical Co., Ltd.